InvestorsHub Logo
Followers 31
Posts 1587
Boards Moderated 0
Alias Born 01/27/2011

Re: SmurfVA post# 2292

Tuesday, 10/08/2013 8:58:00 AM

Tuesday, October 08, 2013 8:58:00 AM

Post# of 4126
I believe it:

In conclusion, Catalyst appears to be an excellent speculation for significant price appreciation based on comparison to Aegerion and Acadia, and also based on the high likelihood of Firdapse being approved by the FDA in 2015. If Catalyst matches the performance of Aegerion and Acadia, and if market conditions remain stable, shares have the potential to appreciate to $41.66 in 12 to 18 months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CPRX News